⌘K

Home/Filings/4/0001127602-25-012941

4//SEC Filing

Nader Francois 4

Accession 0001127602-25-012941

CIK 0001682852other

View on SEC.gov Company Profile

Filed

Apr 30, 8:00 PM ET

Accepted

May 1, 4:33 PM ET

Size

7.6 KB

Accession

0001127602-25-012941

Insider Transaction Report

Form 4

Period: 2025-04-30

Moderna, Inc.MRNA

Director

Transactions

Award
Restricted Stock Units
2025-04-30+12,174→ 12,174 total
→ Common Stock (12,174 underlying)
Award
Stock Option (Right to Buy)
2025-04-30+6,378→ 6,378 total
Exercise: $28.54Exp: 2035-04-30→ Common Stock (6,378 underlying)

Footnotes (3)

[F1]This option will become fully vested and exercisable on the earlier of April 30, 2026, or Moderna's next Annual Meeting of Shareholders, subject to the recipient's continued service.
[F2]Restricted stock units convert into common stock on a one-for-one basis.
[F3]The shares subject to this restricted stock unit award will vest in full on the earlier of April 30, 2026, or Moderna's next Annual Meeting of Shareholders, subject to the recipient's continued service.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

Moderna, Inc.

CIK 0001682852

Entity typeother

Related Parties

1

filerCIK 0001365343

Filing Metadata

Form type: 4
Filed: Apr 30, 8:00 PM ET
Accepted: May 1, 4:33 PM ET
Size: 7.6 KB

View on SEC.gov